Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/19/1996 | US5576321 Compounds having effects on serotonin-related systems |
11/19/1996 | US5576320 1-heteruarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them |
11/19/1996 | US5576318 For treatment of central nervous system disorders |
11/19/1996 | US5576317 NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis |
11/19/1996 | US5576316 Method for inhibiting tumor growth rate using creatine or creatine analogs |
11/19/1996 | US5576313 Enzyme inhibitors and anticarcinogenic agents |
11/19/1996 | US5576312 1-azatricyclo[7.2.0.03,8 ]undec-2-ene-2-carboxylates as antibacterial compounds |
11/19/1996 | US5576311 Cyclodextrins as suspending agents for pharmaceutical suspensions |
11/19/1996 | US5576309 Estradiol derivative-chlorambucil conjugate, process for preparing the same, and pharmaceutical composition |
11/19/1996 | US5576306 Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers |
11/19/1996 | US5576305 Intercellular adhesion mediators |
11/19/1996 | US5576304 Antithrombotic composition |
11/19/1996 | US5576293 Inhibitors of farnesyl-protein transferase |
11/19/1996 | US5576287 Method for treating acute renal disease and failure |
11/19/1996 | US5576025 Gastrointestinal mucosa-adherent matrixes, pharmaceutical preparations and a coating composition |
11/19/1996 | US5576024 Buffered matrix aspirin |
11/19/1996 | US5576022 Controlled release tacrine drug delivery systems and methods for preparing same |
11/19/1996 | US5576021 Hypotensive agents |
11/19/1996 | US5576015 Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses |
11/19/1996 | US5576005 Viricides and topical treatment |
11/19/1996 | US5576001 Of carrots, rice, bananas and glucose |
11/19/1996 | US5575993 Useful as herbicides, microbiocides, plant growth regulators, pharmaceuticals, disinfectants, algicides, sanitizers, and preservatives |
11/19/1996 | US5575988 Combination sunscreen and insect repellent |
11/19/1996 | US5575652 Process for applying antibacterial oral composition to dental implant areas |
11/19/1996 | CA2176414A1 Acyl guanidine and amidine prodrugs |
11/19/1996 | CA2111460C Tetrahydrobenzazepine derivatives which inhibit lipoxygenase |
11/19/1996 | CA2109613C Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles |
11/19/1996 | CA2106200C Stereoselective preparation of substituted piperidines |
11/18/1996 | CA2176415A1 Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ace and nep |
11/17/1996 | CA2176553A1 Fluorine-containing benzoylguanidines |
11/17/1996 | CA2176185A1 Stable microemulsions of certain 3-isothiazolone compounds |
11/14/1996 | WO1996035953A1 Combinatorial synthesis and high-throughput screening of a rev-inhibiting arylidenediamide array |
11/14/1996 | WO1996035805A2 Tripeptidylpeptidase inhibitors |
11/14/1996 | WO1996035793A1 Animal gene therapy |
11/14/1996 | WO1996035787A1 Nucleic acids for treating obesity |
11/14/1996 | WO1996035782A1 Il-6 activity inhibitor |
11/14/1996 | WO1996035720A1 Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions |
11/14/1996 | WO1996035708A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
11/14/1996 | WO1996035707A1 Terpenoid inhibitors of farnesyl-protein transferase |
11/14/1996 | WO1996035702A1 Dialkyltiacumicin compounds |
11/14/1996 | WO1996035701A1 Antibiotics |
11/14/1996 | WO1996035700A1 Saccharopeptides and derivatives thereof |
11/14/1996 | WO1996035698A1 Antimalarial organometallic iron complexes |
11/14/1996 | WO1996035692A1 Antibacterial cephalosporins |
11/14/1996 | WO1996035691A1 Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones |
11/14/1996 | WO1996035689A1 Novel deazapurine derivatives; a new class of crf1 specific ligands |
11/14/1996 | WO1996035687A1 Peptidyl compounds and their therapeutic use |
11/14/1996 | WO1996035681A1 Benzothiazoles and benzoxazoles, as well as drugs containing them, their use and methods of preparing them |
11/14/1996 | WO1996035678A1 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase |
11/14/1996 | WO1996035677A1 Nitric oxide synthase inhibitors derived from cyclic amidines |
11/14/1996 | WO1996035671A1 β-ADRENERGIC AGONISTS |
11/14/1996 | WO1996035670A1 β-ADRENERGIC AGONISTS |
11/14/1996 | WO1996035667A1 Alpha-(substituted alkylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidine butanol derivatives, their preparation and their use as anti-histamines, anti-allergy agents and bronchodilators |
11/14/1996 | WO1996035666A1 Benzyl piperidine derivatives as pharmaceutical agents |
11/14/1996 | WO1996035661A1 Surfactants containing quaternary-nitrogen groups |
11/14/1996 | WO1996035453A2 Endothelin antagonists and endothelin synthase inhibitors for the prevention and treatment of interine contractility disorders, preeclampsia, atherosclerotic vascular disease, hypertension and or hormone replacement therapy |
11/14/1996 | WO1996035452A1 Pharmaceutical composition containing acetylcysteine, carbocysteine or erdosteine in combination with a beta 2 agonist and an expectorant for the treatment of respiratory tract disorders |
11/14/1996 | WO1996035446A1 Treatment of alzheimer disease by modulation of synapsins |
11/14/1996 | WO1996035445A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent |
11/14/1996 | WO1996035441A1 Pharmaceutical compositions for the treatment of alcohol addiction |
11/14/1996 | WO1996035440A1 Pharmaceutical composition comprising lactobacillus plantarum and arginine |
11/14/1996 | WO1996035436A1 Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders |
11/14/1996 | WO1996035435A1 Compositions containing bismuth, for the treatment and prevention of gastrointestinal disorders |
11/14/1996 | WO1996035433A1 N,o-carboxymethylchitosan for prevention of surgical adhesions |
11/14/1996 | WO1996035430A1 REMEDY AND PREVENTIVE FOR DISEASES CAUSED BY NF-λB |
11/14/1996 | WO1996035429A1 Use of non-steroidal anti-inflammatory agents to improve the physiological compatibility of particular pharmaceutical preparations |
11/14/1996 | WO1996035428A1 Pharmaceutical compositions containing steroid derivatives involved in triggering an immune response |
11/14/1996 | WO1996035427A1 Transdermal therapeutic system for administering testosterone |
11/14/1996 | WO1996035426A1 Compounds useful for concurrently activating glucocorticoid-induced response and reducing multidrug resistance |
11/14/1996 | WO1996035425A1 A pharmaceutical composition useful in treating alcohol dependence or abuse comprising at least one partial agonist of 5-th1a receptors and at least one selective inhibitor of monoamino-oxidase |
11/14/1996 | WO1996035424A1 Aryl-imidazolines and aryl-imidazoles useful as alpha-2 adrenergic agonists without cardiovascular side effects |
11/14/1996 | WO1996035423A1 Antifungal composition |
11/14/1996 | WO1996035422A1 Methods for inhibiting bone loss |
11/14/1996 | WO1996035421A1 High-dose chromic tripicolinate for the treatment of type ii diabetes |
11/14/1996 | WO1996035420A1 Use of(s)-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure |
11/14/1996 | WO1996035419A1 Combination of methotrexate and tenidap for the treatment of rheumatoid arthritis |
11/14/1996 | WO1996035418A1 Method for inhibiting the binding of selectins to sialyl-lewises |
11/14/1996 | WO1996035417A1 Combinations of anti-oestrogen compounds and pkc modulators and their use in cancer therapy |
11/14/1996 | WO1996035416A1 Localized use of nitric oxideadducts to prevent internal tissue damage |
11/14/1996 | WO1996035415A2 Use of sesquiterpenes for inhibiting oxidative enzymes |
11/14/1996 | WO1996035407A1 Prevention of tooth loss by the administration of alendronate or its salts |
11/14/1996 | WO1996031208A3 Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders |
11/14/1996 | WO1996028148A3 Use of a r-nsaid in a protective composition for the treatment of colorectal cancer |
11/14/1996 | WO1996027008A3 Agent for treating tumours and other hyperplasia |
11/14/1996 | WO1996024378A3 Delivery of exogenous compounds |
11/14/1996 | WO1996022068A3 Methods and pharmaceutical compositions employing desmethylselegiline |
11/14/1996 | WO1996015148A3 Low molecular weight peptidomimetic growth hormone secretagogues |
11/14/1996 | DE19518221A1 Verwendung nichtsteroidaler Entzündungshemmer zur Verbesserung der physiologischen Verträglichkeit partikulärer pharmazeutischer Zubereitungen Use of non-steroidal anti-inflammatory drugs to improve the physiological tolerance particulate pharmaceutical preparations |
11/14/1996 | DE19517448A1 Neue Benzothiazole und Benzoxazole, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New benzothiazoles and benzoxazoles, pharmaceutical compositions containing them and their use, and processes for their preparation |
11/14/1996 | DE19517251A1 Use of D-(+) pantothenyl-alcohol to treat dry nose |
11/14/1996 | CA2221035A1 Tripeptidylpeptidase inhibitors |
11/14/1996 | CA2220897A1 Treatment of alzheimer disease by modulation of synapsins |
11/14/1996 | CA2220893A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
11/14/1996 | CA2220771A1 Antibiotics |
11/14/1996 | CA2220677A1 Endothelin antagonists and endothelin synthase inhibitors for the prevention and treatment of uterine contractility disorders, preeclampsia, atherosclerotic vascular disease, hypertension and for hormone replacement therapy |
11/14/1996 | CA2220576A1 Combinatorial synthesis and high-throughput screening of a rev-inhibiting arylidenediamide array |
11/14/1996 | CA2220538A1 .beta.-adrenergic agonists |
11/14/1996 | CA2220517A1 Aryl-imidazolines and aryl-imidazoles useful as alpha-2 adrenergic agonists without cardiovascular side effects |
11/14/1996 | CA2220508A1 Saccharopeptides and derivatives thereof |
11/14/1996 | CA2220504A1 Benzyl piperidine derivatives as pharmaceutical agents |